Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent

Critical Pathways in Cardiology

Volumn 6, Issue 1, 2007, Pages 24-25

  Satish, Bhadriraju ^a,b   Tressa, Kellogg ^b   Harish, Chandra R ^c  

^a Baldwin Family Health Care   (United States)

^b Gerber Memorial Hospital   (United States)

^c SPECTRUM HEALTH   (United States)

Author keywords

Coronary stenting; Rash; Thienopyridines

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CLOPIDOGREL; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; TICLOPIDINE;

ADULT; ALLERGIC URTICARIA; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ERUPTION; DRUG WITHDRAWAL; EMERGENCY WARD; FAMILY HISTORY; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MACULOPAPULAR RASH; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; THORAX PAIN; THROMBOSIS; TOBACCO DEPENDENCE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY STENOSIS; DISEASE PROGRESSION; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; EXANTHEMA; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE; TUBULIN MODULATORS; URTICARIA;

EID: 33947119552     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000255061.30935.f4     Document Type: Article

References (9)

1. Holmes DR Jr, Savage M, LaBlanche JM, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2002;106:1243-1250.
2. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
3. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
4. Bertrand ME, Rupprecht HJ, Urban P, et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation. 2000;102:624-629.
5. Kolansky DM, Klugherz BD, Curran SC, et al. Combination therapy with clopidogrel and aspirin after coronary stenting. Catheter Cardiovasc Interv. 2000;50:276-279.
6. Steinhubl SR, Topol EJ. Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting. J Thromb Thrombolysis. 1999;7:227-231.
7. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
8. Balsano F, Rizzon P, Violi F, et al. Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. Circulation. 1990;82:17-26.
9. Scrutinio D, Lagioia R, Rizzon P. Ticlopidine treatment for patients with unstable angina at rest. A further analysis of the study of ticlopidine in unstable angina. Studio della Ticlopidina nell'Angina Instabile Group. Eur Heart J. 1991;12(Suppl G):27-29.